Articles published by KalVista Pharmaceuticals, Inc.
![](https://mms.businesswire.com/media/20240829535812/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240815998817/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240802335240/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240711453276/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
July 11, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240702602098/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240627071012/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240618507569/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240606656084/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240604383516/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240603431601/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240531104408/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240524679559/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240521674499/en/670569/5/Kalvista-Logo-Final-01.jpg)
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240502658624/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240501899140/en/670569/5/Kalvista-Logo-Final-01.jpg)
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240422400971/en/670569/5/Kalvista-Logo-Final-01.jpg)
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240403658389/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240402778985/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240318610099/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240312355965/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240311841357/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
March 11, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240308093167/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240307682920/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240306952725/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240304835396/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 04, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240227931159/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240226691447/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240220763544/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat
February 20, 2024
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20240216185634/en/670569/5/Kalvista-Logo-Final-01.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.